A Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis

Conditions: Rheumatoid Arthritis Interventions: Drug: LNK01001 Dose A; Drug: LNK01001 Dose B; Drug: placebo Sponsors: Lynk Pharmaceuticals Co., Ltd Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials